Preliminary Scientific Program

Preliminary Scientific Program

 Saturday 15 September 2018

9:00 - 10:50 SESSION 6 - Therapeutic session 'New therapeutic strategies '

  • 9:00 - 9:30      Biosimilars in BD - Martin van Hagen (Netherlands)
  • 9:30 - 10:00    Molecular designed agents in BD - Gulen Hatemi (Turkey)
  • 10:00 - 10:30  Targeting IFN-α andγ pathways - speaker tbc
  • 10:30 - 10:50  Update on anti-TNF therapy: timing of tapering - Peter Sfikakis

10:50-11:30 Keynote lecture - The ethics of genetic analysis
                                                          Prof. dr. James Stacey Taylor (USA)

11:30 - 12:00 Closing remarks - Jan van Laar (Netherlands)

12:00-13:00 Executive committee meeting